Magenta Therapeutics is one of seven co-recipients of a five-year, $14.6 million NIH grant that will support research studies to use cell-based and gene therapies to cure HIV. The six other recipients are academic and clinical institutions.
$14.6M NIH grant to support HIV cure research by 7 teams
Sign up for AIChE SmartBrief
News for chemical engineers
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.